- Home
- NERV vs CNTM Comparison
NERV vs CNTM Comparison
Compare NERV & CNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- CNTM
- Stock Information
- Founded
- NERV 2007
- CNTM 2007
- Country
- NERV United States
- CNTM United States
- Employees
- NERV N/A
- CNTM N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- CNTM
- Sector
- NERV Health Care
- CNTM
- Exchange
- NERV Nasdaq
- CNTM NYSE
- Market Cap
- NERV 18.3M
- CNTM 20.9M
- IPO Year
- NERV 2014
- CNTM N/A
- Fundamental
- Price
- NERV $2.20
- CNTM $0.96
- Analyst Decision
- NERV Hold
- CNTM
- Analyst Count
- NERV 1
- CNTM 0
- Target Price
- NERV $5.00
- CNTM N/A
- AVG Volume (30 Days)
- NERV 25.3K
- CNTM 110.3K
- Earning Date
- NERV 11-05-2024
- CNTM 11-27-2024
- Dividend Yield
- NERV N/A
- CNTM N/A
- EPS Growth
- NERV N/A
- CNTM N/A
- EPS
- NERV N/A
- CNTM N/A
- Revenue
- NERV N/A
- CNTM $20,096,828.00
- Revenue This Year
- NERV N/A
- CNTM N/A
- Revenue Next Year
- NERV N/A
- CNTM N/A
- P/E Ratio
- NERV N/A
- CNTM N/A
- Revenue Growth
- NERV N/A
- CNTM 30.15
- 52 Week Low
- NERV $2.10
- CNTM $0.67
- 52 Week High
- NERV $13.49
- CNTM $12.47
- Technical
- Relative Strength Index (RSI)
- NERV 34.31
- CNTM N/A
- Support Level
- NERV $2.26
- CNTM N/A
- Resistance Level
- NERV $2.43
- CNTM N/A
- Average True Range (ATR)
- NERV 0.16
- CNTM 0.00
- MACD
- NERV -0.01
- CNTM 0.00
- Stochastic Oscillator
- NERV 13.71
- CNTM 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About CNTM CONNECTM TECHNOLOGY SOLUTIONS INC
ConnectM Technology Solutions Inc is a clean energy technology and solutions provider. The company provides residential and light commercial buildings and all-electric original equipment manufacturers (OEMs) with a proprietary digital platform to accelerate the transition to solar and all-electric heating, cooling and transportation. The group makes electrification more user-friendly, affordable, precise, and socially meaningful by combining technology, data, artificial intelligence, and contemporary design. In addition to its vertically integrated service network, ConnectM offers customers a comprehensive technology stack that enables them to reduce their fossil fuel consumption, lower their energy bills, and decrease their carbon footprint.